chr7-5987486-G-C
Variant summary
The NM_000535.7(PMS2):c.1279C>G (p.Arg427Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene PMS2 is a cancer driver gene (CancerMine: 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R427C: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 127758); p.R427H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 185424); p.R427L: Uncertain_significance (ClinVar VariationId 2828578, 1 star); p.R427= (synonymous): Likely_benign (ClinVar VariationId 1133919, 2 stars); p.R427= (synonymous): Benign/Likely_benign (ClinVar VariationId 818786, 2 stars)
Frequency
Consequence
NM_000535.7 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 1 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| B3Computational evidence does not support deleterious effect | Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3 |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PMS2 | MANE Select | c.1279C>G p.Arg427Gly | missense | Exon 11 of 15 | Prot: NP_000526.2 UniProt: | |
PMS2 | c.1465C>G p.Arg489Gly | missense | Exon 12 of 16 | Prot: NP_001393795.1 UniProt: | ||
PMS2 | c.1279C>G p.Arg427Gly | missense | Exon 11 of 15 | Prot: NP_001308943.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PMS2 | TSL:1MANE Select | c.1279C>G p.Arg427Gly | missense | Exon 11 of 15 | Prot: ENSP00000265849.7 UniProt: | |
PMS2 | TSL:1 | c.804-4495C>G | intron | Intron 7 of 10 | Prot: ENSP00000371758.4 UniProt: | |
PMS2 | TSL:1 | n.1279C>G | non_coding_transcript_exon | Exon 11 of 13 | Prot: ENSP00000514464.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:31 | ||||
GnomAD4 exome | Cov:34 | ||||
GnomAD4 genome | Cov:31 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 19 | |
AlphaMissense | Benign | 0.10 | |
BayesDel_addAF | Benign | 0.00069 | T |
BayesDel_noAF | Benign | -0.24 | |
CADD | Benign | 19 | |
DANN | Uncertain | 0.99 | |
DEOGEN2 | Benign | 0.11 | T |
Eigen | Benign | -0.079 | |
Eigen_PC | Benign | 0.067 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
FuncVEP CTI | Benign | 0.025 | |
GPN-Star LLR | N/A | -5.1 | |
GPN-Star score | N/A | 5.1 | |
LIST_S2 | Benign | 0.78 | T |
M_CAP | Benign | 0.029 | D |
MetaRNN | Benign | 0.17 | T |
MetaSVM | Uncertain | -0.13 | T |
Mutation Taster | N/A | 56/44 | polymorphism |
MutationAssessor | Benign | 1.4 | L |
PhyloP100 | Uncertain | 4.0 | |
popEVE | Benign | -3.1 | |
PrimateAI | Benign | 0.19 | T |
PROVEAN | Benign | -1.3 | N |
REVEL | Benign | 0.17 | |
Sift | Benign | 0.031 | D |
Sift4G | Benign | 0.20 | T |
Varity_R | N/A | 0.090 | |
VESM-3B | Benign | -5.3 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.